434
Views
23
CrossRef citations to date
0
Altmetric
Review

Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer

, , , , &
Pages 3081-3100 | Published online: 08 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xue Zhang, Xuan Wei, Gaigai Bai, Xueyao Huang, Shunxue Hu, Hongluan Mao & Peishu Liu. (2021) Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis. Cancer Management and Research 13, pages 8629-8646.
Read now

Articles from other publishers (22)

Marek Murawski, Adam Jagodziński, Aleksandra Bielawska-Pohl & Aleksandra Klimczak. (2024) Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications. Cells 13:4, pages 345.
Crossref
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, Joana Assis, Deolinda Pereira & Rui Medeiros. (2024) Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements. International Journal of Molecular Sciences 25:3, pages 1845.
Crossref
Lvfen Gao, Ting Huang, Lijuan Zhong, Lilin Peng, Zhongwei Huang & Yuanzhi Lu. (2024) Fertility-Sparing Surgery and Adjuvant Chemotherapy with Trastuzumab Result in Complete Remission in a Young Woman with Rare Primary Mucinous Ovarian Cancer due to ERBB2 Co-amplification with CDK12 and Chromosome 11q13.3 Amplicon: A Case Report and Literature Review. Reproductive Sciences.
Crossref
J. Bai, Z. J. Jiang, X. P. Zhao, N. N. Wang, A. J. Chen & Y. Z. Luo. (2024) Cancer-Associated Fibroblast-Related Genes Are Associated with Prognosis of Patients with Ovarian Cancer. Russian Journal of Genetics 59:S2, pages S208-S218.
Crossref
Ana Duarte Mendes, Ana Rita Freitas, Rodrigo Vicente, Marina Vitorino, Marta Vaz Batista, Michelle Silva & Sofia Braga. (2023) Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?. International Journal of Molecular Sciences 24:23, pages 16589.
Crossref
Ovidiu-Virgil Maioru, Viorica-Elena Radoi, Madalin-Codrut Coman, Iulian-Andrei Hotinceanu, Andra Dan, Anca-Elena Eftenoiu, Livia-Mălina Burtavel, Laurentiu-Camil Bohiltea & Emilia-Maria Severin. (2023) Developments in Genetics: Better Management of Ovarian Cancer Patients. International Journal of Molecular Sciences 24:21, pages 15987.
Crossref
Syed Aoun Mehmood Sherazi, Fareena Rafique, Muhammad Haris, Abida Arshad, Hammad Qaiser, Mohammad Uzair & Muhammad Arshad. (2023) Applications of CRISPR Cas-9 in Ovarian Cancer Research. Protein & Peptide Letters 30:8, pages 653-667.
Crossref
Ivan Lučić, Matea Kurtović, Monika Mlinarić, Nikolina Piteša, Ana Čipak Čipak Gašparović, Maja Sabol & Lidija Milković. (2023) Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches. International Journal of Molecular Sciences 24:13, pages 10683.
Crossref
Razaul Haque, Jaebon Lee, Joon-Yong Chung, Ha-Yeon Shin, Hyosun Kim, Jae-Hoon Kim, Jae Won Yun & Eun-Suk Kang. (2023) VGLL3 expression is associated with macrophage infiltration and predicts poor prognosis in epithelial ovarian cancer. Frontiers in Oncology 13.
Crossref
Ibolya Czegle, Chelsea Huang, Priscilla Geraldine Soria, Dylan Wesley Purkiss, Andrea Shields & Edina Amalia Wappler-Guzzetta. (2023) The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies. Life 13:4, pages 996.
Crossref
Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak & Aneta Rogalska. (2023) Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival. Cells 12:7, pages 1038.
Crossref
Diana Žilovič, Ieva Vaicekauskaitė, Rūta Čiurlienė, Rasa Sabaliauskaitė & Sonata Jarmalaitė. (2023) Uterine Cavity Lavage Mutation Analysis in Lithuanian Ovarian Cancer Patients. Cancers 15:3, pages 868.
Crossref
Kayode Yomi Raheem, Fawehinmi Praise Ibukunoluwa, Solomon Ayodele Olorundare, Jairus Olumasai Nandwa, Modinat Aina Abayomi, Egbe Justine Uchechukwu, Mary Adewunmi, Kuyet Zichat Blessing, Modupe Mercy Anthony, Mary Ikeoluwa Gbadebo & Falana Taiwo Daniel. (2023) Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach. Advances in Biomarker Sciences and Technology 5, pages 8-32.
Crossref
Dinh-Toi Chu, Suong Mai Vu Ngoc, Yen-Vy Nguyen Thi, Mai-Anh Nguyen, Binh Pham Van, Le Tri Chinh & Pham Gia Anh. 2023.
Eun Jung Sohn. (2022) PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis. BMC Cancer 22:1.
Crossref
Ahmed Ismail, Ahmed I. Abulsoud, Doaa Fathi, Ahmed Elshafei, Hesham A. El-Mahdy, Elsayed G.E. Elsakka, Ahmed Aglan, Samy Y. Elkhawaga & Ahmed S. Doghish. (2022) The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay. Pathology - Research and Practice 240, pages 154222.
Crossref
Paula Punzón-Jiménez, Victor Lago, Santiago Domingo, Carlos Simón & Aymara Mas. (2022) Molecular Management of High-Grade Serous Ovarian Carcinoma. International Journal of Molecular Sciences 23:22, pages 13777.
Crossref
R.O. Oveh, M.A. Adewunmi & G.O. Aziken. (2022) BERTopic Modelling with P53 in Ovarian Cancer. BERTopic Modelling with P53 in Ovarian Cancer.
Emmanuel B. Omole, Iqbal Aijaz, James EllegateJr.Jr., Emily Isenhart, Mohamed M. Desouki, Michalis Mastri, Kristen Humphrey, Emily M. Dougherty, Spencer R. Rosario, Kent L. Nastiuk, Joyce E. Ohm & Kevin H. Eng. (2022) Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers. Cancers 14:19, pages 4724.
Crossref
Dimitra Stergiopoulou, Athina Markou, Lydia Giannopoulou, Paul Buderath, Ioanna Balgkouranidou, Nikolaos Xenidis, Stylianos Kakolyris, Sabine Kasimir-Bauer & Evi Lianidou. (2022) Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients. Cancers 14:15, pages 3790.
Crossref
Lubna Therachiyil, Anjana Anand, Abdullah Azmi, Ajaz Bhat, Hesham M. Korashy & Shahab Uddin. (2022) Role of RAS signaling in ovarian cancer. F1000Research 11, pages 1253.
Crossref
Chiara De Santis & Martin Götte. (2021) The Role of microRNA Let-7d in Female Malignancies and Diseases of the Female Reproductive Tract. International Journal of Molecular Sciences 22:14, pages 7359.
Crossref